000 05277nam a22004695i 4500
001 978-1-4614-8432-5
003 DE-He213
005 20140220082831.0
007 cr nn 008mamaa
008 131010s2013 xxu| s |||| 0|eng d
020 _a9781461484325
_9978-1-4614-8432-5
024 7 _a10.1007/978-1-4614-8432-5
_2doi
050 4 _aR-RZ
072 7 _aMBGR
_2bicssc
072 7 _aMED000000
_2bisacsh
082 0 4 _a610
_223
100 1 _aRepka, Michael A.
_eeditor.
245 1 0 _aMelt Extrusion
_h[electronic resource] :
_bMaterials, Technology and Drug Product Design /
_cedited by Michael A. Repka, Nigel Langley, James DiNunzio.
264 1 _aNew York, NY :
_bSpringer New York :
_bImprint: Springer,
_c2013.
300 _aXII, 474 p. 266 illus., 125 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aAAPS Advances in the Pharmaceutical Sciences Series,
_x2210-7371 ;
_v9
505 0 _aMelt Extrusion in Drug Delivery: Three Decades of Progress -- Twin Screw Extrusion for Pharmaceutical Processes -- Properties and Applications of Polyvinyllactam Polymers -- Properties and Applications of Hypromellose Acetate Succinate (HPMCAS) for Solubility Enhancement Using Melt Extrusion -- Cellulose Ethers for Extrusion Applications -- Properties and Applications of Polyethylene Oxide and Ethylcellulose for Tamper Resistance and Controlled Drug Delivery -- Formulation Development of Amorphous Solid Dispersions Prepared by Melt Extrusion -- Non-Sink In Vitro Dissolution Testing of Amorphous Solid Dispersions -- Manufacture of Pharmaceutically Relevant Materials by Mechanochemistry Using Twin Screw Extrusion -- Melt Extruded Controlled Release Dosage  Forms -- Excipient/API Melt Processing via Injection Molding -- Devices and Implants Prepared Using Hot Melt Extrusion -- Solid Lipid Extrusion -- Formulation, Bioavailability and Manufacturing Process Enhancement: Novel Applications of Melt Extrusion in Enabling Product Development -- Hot Melt Extrusion as a Continuous Pharmaceutical Manufacturing Process -- Hot-Melt Extrusion Process Design Using Process Analytical Technology -- Consistency of Pharmaceutical Products: An FDA Perspective on Hot-melt Extrusion Process -- Melt Extrusion: A Commercial Perception to Practicality -- Future Trends.
520 _aThis inclusive text describes hot melt extrusion for pharmaceutical applications, focusing on the materials used for the preparation of solid dispersions, fundamentals for preparing such systems and novel applications using extrusion technology. Highlighting viewpoints from the academic, excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying hot melt extrusion for drug product development while also providing insight into the path forward for the technology in years to come.  Dr. Michael A. Repka is Chair and Professor of the Department of Pharmaceutics at The University of Mississippi, as well as Director of the Pii Center for Pharmaceutical Technology. His research interests include the solubilization and delivery of poorly soluble bioactives via hot melt extrusion technology. Dr. Repka has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks. Dr. Nigel Langley is currently Head of Marketing and Technical Sales at BASF Corporation where he is responsible for the promotion and technical support for BASF’s pharmaceutical excipients and APIs to the Pharmaceutical Industry in North America.  He has a strong interest in solubilization including hot melt extrusion. He received his Ph.D. in Liquid Crystals from Hull University, U.K., and an M.B.A. from Leeds University, U.K. Prior to joining BASF, he worked for Croda International in the U.K., Japan and the United States. Dr. James DiNunzio is currently an Associate Principal Scientist at Merck & Co., Inc. where he serves as a member of the Hot Melt Extrusion Technology Development Team.  He received his Ph.D. in Pharmacy from the University of Texas at Austin and holds M.S. and B.S. degrees in Chemical Engineering from Columbia University and SUNY Buffalo, respectively.  His research interests include formulation design of amorphous dispersions, development of controlled release products using melt extrusion, continuous manufacturing and engineering of directly shaped drug products.
650 0 _aMedicine.
650 0 _aPharmaceutical technology.
650 1 4 _aBiomedicine.
650 2 4 _aBiomedicine general.
650 2 4 _aPharmaceutical Sciences/Technology.
700 1 _aLangley, Nigel.
_eeditor.
700 1 _aDiNunzio, James.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781461484318
830 0 _aAAPS Advances in the Pharmaceutical Sciences Series,
_x2210-7371 ;
_v9
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4614-8432-5
912 _aZDB-2-SBL
999 _c96054
_d96054